1-3 of 3
Karin Staudacher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.

Susan O'Brien, M.D., David A. Rizzieri, MD, Norbert Vey, Farhad Ravandi, Utz O. Krug, Mikkael A. Sekeres, MD, MS, Mike Dennis, Adriano Venditti, MD, Tove Flem Jacobsen, Karin Staudacher, Bo I Nilsson, MD, PhD, Francis J. Giles, MB, MD, FRCPI, FRCPath
Journal: Blood
Blood (2009) 114 (22): 1042.
https://doi.org/10.1182/blood.V114.22.1042.1042
Published: 2009
Journal Articles

A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies.

Susan O’Brien, M.D., David A. Rizzieri, MD, Norbert Vey, MD, Hagop M Kantarjian, Tove Flem Jacobsen, Bo I Nilsson, MD, PhD, Karin Staudacher, Francis Giles, MD
Journal: Blood
Blood (2008) 112 (11): 949.
https://doi.org/10.1182/blood.V112.11.949.949
Published: 2008
Journal Articles

A Phase I Study with CP-4055 In Patients with Hematologic Malignancies.

Francis Giles, MD, Hagop M. Kantarjian, MD, Norbert Vey, MD, David Rizzieri, MD, Farhad Ravandi, MD, Thomas Prebet, MD, Tove Flem Jacobsen, Bo I. Nilsson, MDPhD, Karin Staudacher, Susan O’Brien, MD
Journal: Blood
Blood (2007) 110 (11): 901.
https://doi.org/10.1182/blood.V110.11.901.901
Published: 2007